Eduardo Candelario-Jalil received his Ph.D. degree in pharmacology from the University of Havana, Cuba in 2002. He did his first postdoctoral training in the Department of Psychiatry at the University of Freiburg, Germany, where he studied the signal transduction pathways responsible for cyclooxygenase (COX)-2 upregulation in primary microglial cells and neurons during neuroinflammatory conditions and cerebral ischemia. He joined the University of New Mexico in 2006 to pursue his postdoctoral training with Dr. Gary A. Rosenberg and later became a Research Assistant Professor in the Department of Neurology at the University of New Mexico in 2008. In July 2011, Dr. Candelario-Jalil joined the Department of Neuroscience, University of Florida in Gainesville as an Assistant Professor. His research studies the neuroinflammatory mechanisms in cerebral ischemia with particular emphasis on cyclooxygenases, prostanoid signaling, and matrix metalloproteinases. The major focus of his research is to determine the role of COX-2 and prostaglandin E2 in the opening of the blood-brain barrier following ischemic stroke. Eduardo's research interests and areas of expertise include neuropathological mechanisms of cerebral ischemia, neurodegeneration and neuroprotection, excitotoxicity, neuronal damage induced by oxidative stress, free radical biology, and matrix metalloproteinases in neurological disease. Candelario-Jalil serves on the Editorial Board of two scientific journals (Journal of Neuroinflammation and Journal of Experimental Stroke and Translational Medicine) and is an Ad Hoc Reviewer for several journals in the neuroscience and pharmacology fields.
Biography Updated on 2 January 2012